Soterios, Pharma

Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate alopecia areata

Published on 08/07/2025 at 18:05 | prnewswire.co.uk

Soterios Pharma Germany Spain England United Kingdom United States of America

en | boerse | 67965431 |